Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) FCF Margin (2016 - 2025)

Historic FCF Margin for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to 42.03%.

  • Macrogenics' FCF Margin fell 958400.0% to 42.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 111.12%, marking a year-over-year decrease of 650100.0%. This contributed to the annual value of 48.06% for FY2024, which is 880500.0% up from last year.
  • Latest data reveals that Macrogenics reported FCF Margin of 42.03% as of Q3 2025, which was down 958400.0% from 214.47% recorded in Q2 2025.
  • Macrogenics' FCF Margin's 5-year high stood at 53.81% during Q3 2024, with a 5-year trough of 1379.39% in Q2 2024.
  • Over the past 5 years, Macrogenics' median FCF Margin value was 175.71% (recorded in 2021), while the average stood at 251.71%.
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by -13613100bps in 2024, then surged by 11649300bps in 2025.
  • Quarter analysis of 5 years shows Macrogenics' FCF Margin stood at 393.61% in 2021, then skyrocketed by 110bps to 39.57% in 2022, then tumbled by -776bps to 267.32% in 2023, then soared by 64bps to 97.57% in 2024, then skyrocketed by 57bps to 42.03% in 2025.
  • Its last three reported values are 42.03% in Q3 2025, 214.47% for Q2 2025, and 359.45% during Q1 2025.